Xiaole Shirley Liu
Xiaole Shirley Liu | |
|---|---|
| 刘小乐 | |
| Education | Peking University Smith College (BA) Stanford University (PhD) |
| Awards | ISCB Fellow (2019) Breast Cancer Research Foundation Investigator ISCB Innovator Award (2020) Benjamin Franklin Award (Bioinformatics) (2020) AIMBE Fellow (2022) |
| Scientific career | |
| Fields | |
| Institutions | Dana–Farber Cancer Institute Harvard University GV20 Therapeutics |
| Thesis | Discovery of transcription factor binding sites using computational statistics (2002) |
| Doctoral advisor | Douglas Brutlag Jun S. Liu |
| Website | liulab-dfci |
Xiaole Shirley Liu (Chinese: 刘小乐) is a computational biologist, cancer researcher, and entrepreneur. She has been a Professor in the Department of Data Sciences at the Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health. She co-founded GV20 Therapeutics and, in early 2022, left DFCI to become its full-time CEO.